Farkas K - Search Results

1

A review on biosimilar infliximab, CT-P13, in the treatment of inflammatory bowel disease.

Farkas K, Molnár T. Farkas K, et al. Immunotherapy. 2018 Feb;10(2):107-117. doi: 10.2217/imt-2017-0107. Epub 2017 Nov 10. Immunotherapy. 2018. PMID: 29124994 Review.

2

Successful use of infliximab for treating fistulizing pouchitis with severe extraintestinal manifestation: a case report.

Molnar T, Farkas K, Nagy F, Wittmann T. Molnar T, et al. Among authors: farkas k. Inflamm Bowel Dis. 2008 Dec;14(12):1752-3. doi: 10.1002/ibd.20485. Inflamm Bowel Dis. 2008. PMID: 18452207 No abstract available.

3

RDW can be a useful additional marker in diagnosing Crohn's disease and ulcerative colitis.

Molnar T, Farkas K, Szepes Z, Nagy F, Nyari T, Wittmann T. Molnar T, et al. Among authors: farkas k. Dig Dis Sci. 2008 Oct;53(10):2828-9. doi: 10.1007/s10620-008-0345-4. Epub 2008 Jul 16. Dig Dis Sci. 2008. PMID: 18629645 No abstract available.

4

Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease.

Nagy F, Molnar T, Szepes Z, Farkas K, Nyari T, Lonovics J. Nagy F, et al. Among authors: farkas k. World J Gastroenterol. 2008 Jul 21;14(27):4342-6. doi: 10.3748/wjg.14.4342. World J Gastroenterol. 2008. PMID: 18666323 Free PMC article.

5

Ulcerative colitis and primary sclerosing cholangitis as part of autoimmune polyglandular syndrome type III.

Farkas K, Nagy F, Kovács L, Csajbók E, Kovács G, Wittmann T, Molnár T. Farkas K, et al. Inflamm Bowel Dis. 2010 Jan;16(1):10-1. doi: 10.1002/ibd.20913. Inflamm Bowel Dis. 2010. PMID: 19322903 No abstract available.

6

Topically administered infliximab can work in ulcerative proctitis despite the ineffectiveness of intravenous induction therapy.

Molnár T, Farkas K, Nagy F, Németh I, Wittmann T. Molnár T, et al. Among authors: farkas k. Am J Gastroenterol. 2009 Jul;104(7):1857-8. doi: 10.1038/ajg.2009.147. Epub 2009 May 12. Am J Gastroenterol. 2009. PMID: 19436284 No abstract available.

7

Sulfasalazine-induced nephrotic syndrome in a patient with ulcerative colitis.

Molnár T, Farkas K, Nagy F, Iványi B, Wittmann T. Molnár T, et al. Among authors: farkas k. Inflamm Bowel Dis. 2010 Apr;16(4):552-3. doi: 10.1002/ibd.21049. Inflamm Bowel Dis. 2010. PMID: 19637363 No abstract available.

8

Preserved Na(+)/H(+) exchanger isoform 3 expression and localization, but decreased NHE3 function indicate regulatory sodium transport defect in ulcerative colitis.

Yeruva S, Farkas K, Hubricht J, Rode K, Riederer B, Bachmann O, Cinar A, Rakonczay Z, Molnár T, Nagy F, Wedemeyer J, Manns M, Raddatz D, Musch MW, Chang EB, Hegyi P, Seidler U. Yeruva S, et al. Among authors: farkas k. Inflamm Bowel Dis. 2010 Jul;16(7):1149-61. doi: 10.1002/ibd.21183. Inflamm Bowel Dis. 2010. PMID: 20027604

9

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.

Papp M, Lakatos PL, Harsfalvi J, Farkas G, Palatka K, Udvardy M, Molnar T, Farkas K, Nagy F, Veres G, Lakatos L, Kovacs A, Dinya T, Kocsis AK, Papp J; Hungarian IBD Study Group; Altorjay I. Papp M, et al. Among authors: farkas g, farkas k. Hum Immunol. 2010 Apr;71(4):407-13. doi: 10.1016/j.humimm.2010.01.012. Epub 2010 Jan 26. Hum Immunol. 2010. PMID: 20079790

10

Autoimmune hemolytic anemia associated with ulcerative colitis: the most important step is to induce complete remission.

Molnár T, Farkas K, Szepes Z, Nagy F, Wittmann T. Molnár T, et al. Among authors: farkas k. Am J Gastroenterol. 2010 May;105(5):1203-4; author reply 1204. doi: 10.1038/ajg.2009.751. Am J Gastroenterol. 2010. PMID: 20445515 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

563 results

Search Page